Influence of hormonal status on thermography findings in breast cancer

Acta Clinica Croatica

Volumn 52, Issue 1, 2013, Pages 35-42

  Zore, Zvonimir ^a   Boras, Ivanka ^b   Stanec, Mladen ^a   Orešić, Tomislav ^a   Zore, Irina Filipović ^c  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Breast cancer; Hormone receptors; Infrared thermography

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARITHMETIC; ARTICLE; BREAST CANCER; CANCER PATIENT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFRARED PHOTOGRAPHY; MAJOR CLINICAL STUDY; THERMOGRAPHY; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HEALTH CARE SURVEYS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY; THERMOGRAPHY;

EID: 84888790074     PISSN: 03539466     EISSN: 13339451     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. FITZGERALD A, BERENTSON-SHAW J. Thermography as a screening and diagnostic tool: a systematic review. N Z Med J 2012;125:80-91.
2. KONTOS M, WILSON R, FENTIMAN I. Digital infrared thermal imaging (DITI) of breast lesions: sensitivity and specificity of detection of primary breast cancers. Clin Radiol 2011;66:536-9.
3. WISHART GC, CAMPISI M, BOSWELL M, CHAPMAN D, SHACKLETON V, IDDLES S, HALLETT A, BRITTON PD. The accuracy of digital infrared imaging for breast cancer detection in women undergoing breast biopsy. Eur J Surg Oncol 2010;36:535-40.
4. ARORA N, MARTINS D, RUGGERIO D, TOUSIMIS E, SWISTEL AJ, OSBORNE MP, SIMMONS RM. Effectiveness of a noninvasive digital infrared thermal imaging system in the detection of breast cancer. Am J Surg 2008;196:523-6.
5. GUIDI AJ, SCHNITT SJ. Angiogenesis in preinvasive lesions of breast. Breast J 1996;6:364-9.
6. GAMAGAMI P. Indirect signs of breast cancer: Angiogenesis study. In: Gamagami P, editor. Atlas of mammography. Cambridge, Mass: Blackwell Science, 1996;321-6.
7. ANBAR M. Breast cancer. In: Anbar M, editor. Quantitative dynamic telethermometry in medical diagnosis and management. Ann Arbor, Mich: CRC Press, 1994;84-91.
8. ANBAR M. Clinical thermal imaging today. IEEE Eng Med Biol 1998;7:25-33.
9. SHOZO O, SHIGEMITSU T, KENJIRO A, HISASHI U. Prognostic value of thermographic findings in patients with primary breast cancer. Breast Cancer Res Treat 2002;7:213-20.
10. WANG J, SHIH TT, YEN RF, LU YS, CHEN CY, MAO TL, LIN CH, KUO WH, TSAI YS, CHANG KJ, CHIEN KL. The association of infrared imaging findings of the breast with hormone receptor and human epidermal growth factor receptor 2 status of breast cancer. Acad Radiol 2011;18:212-9.
11. OGAWA Y, MORIYA T, KATO Y, OGUMA M, IKEDA K, TAKASHIMA T, NAKATA B, ISHIKAW T, HIRAKAWA K. Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy. Breast Cancer 2004;11:267-75.
12. ZORE Z, BORAS I, FILIPOVIC-ZORE I, STANEC M, LESAR M, VRDOLJAK DV. The impact of human epidermal growth factor receptor-2 status of invasive breast tumors on thermography findings. Saudi Med J 2012;33:1118-21.
13. DILHUYDY MH, Le TREUT A, DURAND M, AVRIL A, LAGARDE C. The importance of thermography in the prognostic evaluation of breast cancers. Acta Thermograph 1978;3:130-6.
14. FOURNIER VD, KUBLI F, KLAPP J, WEBER E, SCHNEIDER-AFFELD F. Infra-red thermography and breast cancer doubling time. Acta Thermograph 1978;3:107-11.
15. GROS D, GAUTHERIE M, WARTER F. Thermographic prognosis of treated breast cancers. Acta Thermograph 1981;6:107-14.
16. AMALRIC D, GIRAUD D, ALTSCHULE C, SPITALIER JM. Value and interest of dynamic telethermography in detection of breast cancer. Acta Thermograph 1976;1:89-96.
17. HEAD NY, WANG F, ELLIOTT RL. Breast thermography as a noninvasive prognostic procedure predicts tumor growth rate in breast cancer patients. Ann N Y Acad Sci 1993;698:153-8.
18. STERNS EE, ZEE B, SEN GUPTA J, SAUNDERS FW. Thermography: its relation to pathologic characteristics, vascularity, proliferative rate and survival of patients with invasive ductal carcinoma of the breast. Cancer 1996;77:1324-8.
19. MOASSER MM. The oncogene HER2: its signalling and transforming functions and its role in human cancer pathogenesis. Oncogene 2007;26:6469-87.
20. WILLIAM DF, IAN ES, JORGE S. Triple-negative breast cancer. N Engl J Med 2010;363:1938-48.
21. NADJI M, GOMEZ-FERNANDEZ C, GANJEI-AZAR P. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5993 breast cancers. Am J Clin Pathol 2005;123:21-7.
22. CREIGHTON CJ, KENT OSBORNE C, van de VIJVER MJ, FOEKENS JA, KLIJN JG, HORLINGS HM, NUYTEN D, WANG Y, ZHANG Y, CHAMNESS GC, HILSENBECK SG, LEE AV, SCHIFF R. Molecular profiles of progesterone receptor loss in human breast tumors. Breast Cancer Res Treat 2009;114:287-99.
23. PETRIČEVIĆ J, PETKOVIĆ M, JONJIĆ N. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there difference between premenopausal and postmenopausal women? Acta Clin Croat 2011;50:169-75.
24. GUTIERREZ C, SCHIFF R.HER 2: biology, detection, and clinical implications. Arch Pathol Lab Med 2011;135:55-62.